Could Pfizer Stock Help You Become a Millionaire?
Having at least $1 million in the bank by retirement has long been a popular goal, but it isn't easy to accomplish. One of the best ways to do so is to invest in stocks, and the earlier one starts, the better. Naturally, all stocks aren't created equal, and while some will substantially contribute to making investors millionaires, others might do the opposite.
Which of these categories does pharmaceutical giant (NYSE: PFE) fall into? Let's find out whether this drugmaker can help investors become part of the seven-figure club.
Suppose an investor starts with capital of $100,000 and has 20 years to reach $1 million. This would require a compound annual growth rate (CAGR) of 12.2%, which isn't easy to pull off. Investors might rightly be skeptical regarding Pfizer's ability to deliver such returns in the next two decades. For one, the company's performance has been catastrophic this year. Also, even in the past 20 years, Pfizer hasn't been able to beat the market -- quite the opposite, in fact.
Source Fool.com
Pfizer Inc. Aktie
Die Community neigt bei Pfizer Inc. zu Buy-Einschätzungen, mehr als zu Sell-Einschätzungen.
Das Community-Kursziel von 29 € für Pfizer Inc. deutet auf eine deutliche Steigerung um mehr als 20% gegenüber dem aktuellen Kurs von 22.86 € hin.
